foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

PhoreMost raises £11m Series A round to progress t...

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Investorview: Driving early-stage investment in UK...

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

£29m Series B spurs Enterprise Therapeutics’ muco-...

Key learnings:

Read More

Brexit: Life Sciences - House of Commons Issues Re...

On 21 March 2018, the UK House of Commons Health and Social Care Committee ...

Read More

Surge in UK pharma and biotech patent filings show...

In its latest annual report and statistical release, the European Patent Of...

Read More

Brexit developments and their impact on intellectu...

Boult Wade Tennant is pleased to report that on 19 March 2018, the UK and E...

Read More

Zilico’s diagnostic device moves towards Chinese a...

Key learnings: UK-based Zilico has entered into a strategic deal with MaxHe...

Read More

Attracting investment from a leading EIS fund

We talk to CEO David Venables off the back of Synpromics securing £2.1m EIS...

Read More

Life science IPOs: listing in UK or US

The decision to take a company public is never taken lightly. For life scie...

Read More

Add Your Response